Browsing by Author "Santi, Ana Maria Murta"

Apesar da vacinação ser considerada a melhor estratégia para prevenir a infecção por Leishmania, não existe até o momento nenhuma vacina segura e eficaz para uso humano disponível. As vacinas atenuadas, consideradas padrão ...

Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony

Fonseca, Maisa Santos da et al. | Date Issued: 2017

Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential

Ribeiro, Juliana Martins et al. | Date Issued: 2022

The heterologous expression of Escherichia coli MutT enzyme is involved in the protection against oxidative stress in Leishmania braziliensis

Andrade, Laila de Carvalho et al. | Date Issued: 2020

Browsing by Author "Santi, Ana Maria Murta"

Anti-Leishmania compounds can be screened using Leishmania spp. expressing red fluorescence (tdTomato) ﻿

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy ﻿

Deletion of the lipid droplet protein kinase gene affects lipid droplets biogenesis, parasite infectivity, and resistance to trivalent antimony in Leishmania infantum ﻿

Disruption of multiple copies of the Prostaglandin F2alpha synthase gene affects oxidative stress response and infectivity in Trypanosoma cruzi ﻿

Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility ﻿

Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice ﻿

Impact of Genetic Diversity and Genome Plasticity of Leishmania spp. in Treatment and the Search for Novel Chemotherapeutic Targets ﻿

Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony ﻿

Obtenção e caracterização de uma cepa atenuada de Leishmania Infantum mediante deleção do gene Kharon1 ﻿

Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony ﻿

Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential ﻿

The heterologous expression of Escherichia coli MutT enzyme is involved in the protection against oxidative stress in Leishmania braziliensis ﻿

Anti-Leishmania compounds can be screened using Leishmania spp. expressing red fluorescence (tdTomato)

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy

Deletion of the lipid droplet protein kinase gene affects lipid droplets biogenesis, parasite infectivity, and resistance to trivalent antimony in Leishmania infantum

Disruption of multiple copies of the Prostaglandin F2alpha synthase gene affects oxidative stress response and infectivity in Trypanosoma cruzi

Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility

Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice

Impact of Genetic Diversity and Genome Plasticity of Leishmania spp. in Treatment and the Search for Novel Chemotherapeutic Targets

Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony

Obtenção e caracterização de uma cepa atenuada de Leishmania Infantum mediante deleção do gene Kharon1

Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony

Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential

The heterologous expression of Escherichia coli MutT enzyme is involved in the protection against oxidative stress in Leishmania braziliensis